Showing posts with label Urology. Show all posts
Showing posts with label Urology. Show all posts

Thursday, 10 April 2025

AI and Machine Learning in Urology: Current Uses and Future Directions | Chapter 8 | Science and Technology: Developments and Applications Vol. 8

Background: Artificial Intelligence (AI) and Machine Learning (ML) have significantly transformed modern urology by enhancing diagnostic accuracy, surgical precision, and patient management. AI-driven innovations are increasingly integrated into urological practice, enabling early disease detection, predictive analytics, risk stratification, and robotic-assisted surgeries. This paper explores the current landscape of AI in urology, analyzing its applications in diagnostics, treatment planning, and surgical interventions. It highlights AI-driven technologies' benefits, challenges, and future research directions in optimizing patient care.

 

Methods: A comprehensive literature review was conducted on AI applications in urology, examining studies on machine learning models—including deep learning and reinforcement learning—for detecting prostate, kidney, and bladder cancer, predictive analytics for disease progression, and AI-enhanced robotic surgeries. The analysis encompasses regulatory considerations, ethical implications (including data bias and patient privacy concerns), and real-world applications of AI in clinical settings.

 

Results: AI performs superiorly in diagnostic imaging, histopathological analysis, and personalized treatment recommendations. Machine learning models enhance risk stratification, enabling more targeted therapeutic approaches. AI-driven robotic surgical systems enhance precision and reduce complications, while AI-powered remote monitoring tools optimize postoperative care. However, data bias, interpretability, regulatory constraints, and ethical concerns hinder widespread adoption.

 

Conclusion: AI is revolutionizing urology by improving efficiency, accuracy, and patient outcomes. Future advancements in AI-driven precision medicine, autonomous robotic surgery, and AI-integrated telemedicine are promising. Addressing challenges related to data privacy, bias mitigation, and regulatory approval will be crucial for the seamless integration of AI into urological practice. Continued research and interdisciplinary collaboration will enhance AI's role in transforming urological healthcare.

 

Author (s) Details

Aadhitya Sriram
Department of Computer Science and Engineering, College of Engineering, Guindy Anna University, Chennai, Tamil Nadu -600025, India.

 

Shreenidhi Sriram
Meta via PwC, Seattle, USA.

 

Kalpana Ramachandran
Department of Anatomy, Sri Ramachandra Institute of Higher Education & Research (SRIHER), Chennai, Tamil Nadu, PIN: 600116, India.

 

Sriram Krishnamoorthy
Department of Urology & Renal Transplantation, Sri Ramachandra Institute of Higher Education & Research (SRIHER), Chennai, Tamil Nadu, PIN: 600116, India.

 

Please see the book here:- https://doi.org/10.9734/bpi/stda/v8/5018

Monday, 10 February 2025

Newer Frontiers in Urology | Book Publisher International

The field of urology is undergoing a rapid evolution, shaped by groundbreaking research, innovative technologies, and a deeper understanding of patient-centred care. Newer Frontiers in Urology presents a comprehensive exploration of these transformative developments, offering readers an invaluable resource that bridges current practices with future possibilities. This book delves into cutting-edge topics such as minimally invasive surgical techniques, advancements in imaging modalities, and the growing role of artificial intelligence in diagnostics and treatment planning.

 

Key chapters address emerging therapies for challenging urological conditions, including genitourinary cancers, urinary tract infections, and stone disease. Contributions from leading experts highlight the integration of precision medicine, biomarkers, and genetic insights into personalized patient care. The text also considers the global impact of urological diseases, emphasizing equity in access to innovations and the need for collaborative international efforts.

 

By combining rigorous scientific analysis with practical applications, Newer Frontiers in Urology serves as an essential guide for clinicians, researchers, and healthcare professionals eager to stay at the forefront of their field. With its focus on innovation and patient outcomes, this volume inspires a forward-thinking approach to urology, underscoring the discipline's potential to improve lives worldwide.

 

Author (s) Details

Sriram Krishnamoorthy
Professor & Head, Department of Urology, Sri Ramachandra Institute of Higher Education & Research, Chennai, Tamil Nadu, India.

 

Please see the book here:- https://doi.org/10.9734/bpi/mono/978-93-49238-86-2/CH0

Monday, 8 May 2023

SP’z Series New Insights on Urology and Urological Research Part II | Book Publisher International

The practice of Urology has undergone evolutionary changes in the last few decades’ right from clinical signs symptoms to the recent investigation era of Evidence Based Medicine, but still importance of clinical examination and bed side teaching will never fade. This book is envisaged to provide a range of learning avenues to reinforce the concepts and reiterate the minute details in Urology, Urogynaecology and related Obstetrics. This book will be a good source for research topics unique to the Indian urology scenario unlike others which have higher western influences which are nearly impossible in the Indian scenario where affordability is a major factor in making treatment decisions.

Author(s) Details:


Dr. Sanjay P. Dhangar,
Senior Consultant Urologist, Medicover Hospital, Sangamner, India.

Dr. Amrapali D. Gosavi,
Senior Consultant Obstetrician & Gynaecologist, Medicover Hospital, Sangamner, India.

Dr. Sushant S. Gite,
Senior Consultant Physician, Medicover Hospital, Sangamner, India.

Please see the link here: https://stm.bookpi.org/SSNIUURP/article/view/10467

Thursday, 23 February 2023

Retrospective Analysis of Urinary Tract Infection in the Pediatric Population at a Tertiary Care Centre | Chapter 13 | Research Highlights in Disease and Health Research Vol. 2Retrospective Analysis of Urinary Tract Infection in the Pediatric Population at a Tertiary Care Centre | Chapter 13 | Research Highlights in Disease and Health Research Vol. 2

 Background: Urinary area infection (UTI) is among ultimate common contaminations occurring during period of being young. It is caused by both grandam-negative and gram-beneficial bacteria and Escherichia coli is the most average causative agent.Methods: Data of all pediatric inmates in the age group of 6 months to 18 years accompanying urinary tract contamination were taken for analysis. Urine samples were calm and cultured on the cystine lactose electrolyte- inadequate medium. The presence of microorganisms was identified using biochemicals, and the antimicrobial test was acted using the Kirby-Bauer test or the VITEK 2 compact system (bioMérieux, Inc., France).Results: The predominance of UTI was 23.5%. In total, 614 specimens proven positive with important bacteriuria. The male-to-female ratio was 1:2.3. Approximately 54% patients bestowed with urinary syndromes alone. Culture positivity was considerably associated with pyuria (p < 0.0001). E. coli (334/614) was the most universal isolate, attended by Enterococcus spp. (92/614). Colistin, polymyxin B, fosfomycin, nitrofurantoin, netilmicin, and amikacin were extremely good acting antimicrobials. Meanwhile, ampicillin, cefotaxime, ceftriaxone, and norfloxacin were well resistant to gram-negative microorganisms. Multidrug- resistant bacteria and lengthened-spectrum being tested-lactamase-producing bacteria were in the direction of 47% and 44.1% of cases, respectively. Vancomycin, linezolid, teicoplanin, and nitrofurantoin were highly productive against gram-certain bacteria. Furthermore, norfloxacin, trimethoprim/sulfamethoxazole, ciprofloxacin, and tetracycline were very resistant to gram-helpful bacteria. Of the 92, 42 Enterococcus spp. were opposing to high-dose gentamicin.Conclusion: Nitrofurantoin and amikacin maybe used as empirical remedy for gram-negative and grandam- positive bacteria. Because fighting to various commonly secondhand antibiotics is found expected increasing, situation must be guided by antibiotic susceptibleness reports.

Author(s) Details:

Naz Perween,
Department of Microbiology, Post Graduate Institute of Child Health, Noida, India.

Sumit Rai,
Department of Microbiology, All India Institute of Medical Sciences, Mangalagiri, Mangalagiri, India.

Sumi Nandwani,
Department of Microbiology, Post Graduate Institute of Child Health, Noida, India.

Shyam Kishor Kumar,
Department of Microbiology, All India Institute of Medical Sciences, Mangalagiri, Mangalagiri, India.

Please see the link here: https://stm.bookpi.org/RHDHR-V2/article/view/9663

Friday, 12 August 2022

SP'z Series New Insights on Urology and Urological Research Part I | Book Publisher International

From clinical signs and symptoms to the more recent research era of evidence-based medicine, the practise of urology has undergone evolutionary changes over the past few decades, but the significance of clinical examination and bedside instruction will never diminish. This book is intended to offer a variety of educational opportunities to repeat key ideas and specifics in urology. In contrast to other books with greater western influences, which are nearly impossible in the Indian context where affordability is a major factor in determining treatment decisions, this book will be an excellent source for research themes specific to the Indian urological scenario.

 

Author (s) Details

Dr. Sanjay P. Dhangar

Department of General Surgery (Urology), SMBT IMS & Research Centre, Nandi Hills, Dhamangaon, Post – Ghoti, Taluka – Igatpuri, District – Nashik, PIN – 422403, Maharashtra, India.

 

Please see the link here:-  https://stm.bookpi.org/SPSNIUUR-P1/issue/view/740